Figures & data
Table 1. Studies on the targeting preparation of TCM.
Dai M, Xu X, Song J, et al. (2011). Preparation of camptothecin-loaded PCEC microspheres for the treatment of colorectal peritoneal carcinomatosis and tumor growth in mice. Cancer Lett 312:189–96 Tamilvanan S. (2009). Formulation of multifunctional oil-in-water nanosized emulsion for active and passive targeting of drugs to otherwise inaccessible internal organs of the human body. Int J Pharm 381:62–76 Cao ZH, Tong R, Mishra A, et al. (2009). Reversible cell-specific drug delivery with aptamer-functionalized liposomes. Drug Deliver 48:6494–8 Liang HF, Chen CT, Chen SC, et al. (2006). Paclitaxel-loaded poly(γ-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Biomaterials 27:2051–9 Ganta S, Devalapally H, Shahiwala A, Amiji M. (2008). A review of stimuli-responsive nanocarriers for drug and gene delivery. J Contr Rel 126:187–204 Hua MY, Yang HW, Chuang CK, et al. (2010). Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate cancer. Biomaterials 31:7355–63 Wang K, Xing JF, Li XY, et al. (2012). Fabrication of novel magnetic nanoparticles-coated P(styrene-itaconic acid-divinylbenzene) microspheres. Carbohyd Polym 87:2712–17 Paciotti GF, Kingston DGI, Tamarkin L. (2006). Colloidal gold nanoparticles: a novel nanoparticles platform for developing multifunctional tumor-targeted drug delivery vector. Drug Develop Res 67:47–54 Potineni A, Lynn DM, Langer R, Amiji MM. (2003). Poly(ethylene oxide)-modified poly(β-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery. J Contr Rel 86:223–34